Prior studies in MPN mouse models, predominantly manifesting PV phenotypes, have demonstrated that IFNα can directly target JAK2V617F HSCs through pro-apoptotic mechanisms, in addition to proliferation-associated exhaustion [73,74,75]. Here, IFNA2 is linked to myeloproliferative disorder.